Nebulizer therapy in post-operative atelectasis: A narrative review
1 Department of General & Gastro Intestinal Surgery, PSG Hospitals, Peelamedu, Coimbatore, Tamil Nadu, India – 641004.
2 Department of Pharmacy Practice, PSG College of Pharmacy, Peelamedu, Coimbatore, Tamil Nadu, India – 641004.
Review
World Journal of Biology Pharmacy and Health Sciences, 2024, 19(01), 511–519.
Article DOI: 10.30574/wjbphs.2024.19.1.0368
Publication history:
Received on 07 May 2024; revised on 27 July 2024; accepted on 30 July 2024
Abstract:
Atelectasis, the collapse of lung tissue, is a significant complication following surgical procedures, particularly in thoracic or abdominal surgeries. Nebulizer therapy has emerged as a potential adjunctive treatment for post-operative atelectasis, aiming to improve lung expansion, mucociliary clearance, and patient outcomes. This narrative review provides a comprehensive analysis of nebulizer therapy in post-operative atelectasis management, covering its mechanisms of action, clinical effectiveness, safety considerations, challenges, and future perspectives. The review highlights the pathophysiology of post-operative atelectasis, emphasizing anesthesia-induced hypoventilation, loss of functional residual capacity, impaired mucociliary clearance, and airway obstruction. It discusses the role of nebulizer therapy in delivering pharmacological agents, such as bronchodilators, mucolytics, and inhaled corticosteroids, directly to the airways to alleviate atelectasis-associated symptoms and promote lung re-expansion. Safety considerations, including the risk of bronchospasm, infection control, drug-related adverse effects, and environmental hazards, are addressed. Furthermore, patient management strategies, challenges, and limitations of nebulizer therapy, comparative analysis of nebulizer types, and special population considerations are explored. Future perspectives focus on personalized therapy, novel drug formulations, smart nebulizer devices, and targeted therapies to optimize atelectasis management. In conclusion, while nebulizer therapy demonstrates efficacy in treating atelectasis, ongoing advancements in technology and therapeutic strategies offer opportunities to overcome challenges and improve treatment outcomes, ultimately enhancing patient care and quality of life.
Keywords:
Atelectasis; Post Surgery Complications; Nebulizer therapy; Bronchodilators; Post operative patients
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0